T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Rollins
ROL
$17.4B
| $123M | 0.03% |
10,210,689
+1,226,146
| +14% | +$14.5M |
|
502
Southwest Gas
SWX
$6.67B
| $123M | 0.03% |
1,861,020
-7,600
| -0.4% | -$458K |
|
503
DuPont de Nemours
DD
$19.5B
| $122M | 0.03% |
950,598
-50,037
| -5% | -$6M |
|
504
Insmed
INSM
$27.6B
| $122M | 0.03% |
9,645,081
+368,935
| +4% | +$4.85M |
|
|
P
505
Everpure Inc
P
$39B
| $121M | 0.03% |
9,122,770
+2,800
| +0% | +$37.2K |
|
506
Novavax
NVAX
$1.34B
| $121M | 0.03% |
1,171,944
+34,994
| +3% | +$3.75M |
|
507
Alexandria Real Estate Equities
ARE
$8.33B
| $121M | 0.03% |
1,329,435
+435,105
| +49% | +$35.4M |
|
508
ESCO Technologies
ESE
$7.79B
| $120M | 0.03% |
3,076,220
+36,800
| +1% | +$1.3M |
|
509
Kemper
KMPR
$1.59B
| $119M | 0.03% |
4,038,027
+659,450
| +20% | +$19.8M |
|
510
Mine Safety
MSA
$7.32B
| $119M | 0.03% |
2,466,040
-89,760
| -4% | -$3.87M |
|
511
RLJ Lodging Trust
RLJ
$1.67B
| $118M | 0.03% |
5,172,301
+390,689
| +8% | +$7.88M |
|
|
CAM
512
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $118M | 0.03% |
1,761,099
-162,201
| -8% | -$10.4M |
|
513
Lazard
LAZ
$4.43B
| $116M | 0.02% |
2,982,667
+2,322,143
| +352% | +$83.3M |
|
|
SBNY
514
DELISTED
Signature Bank
SBNY
| $114M | 0.02% |
840,088
+64,805
| +8% | +$8.83M |
|
515
Steris
STE
$23B
| $114M | 0.02% |
1,607,731
+11,600
| +0.7% | +$785K |
|
516
Pool Corp
POOL
$7.29B
| $114M | 0.02% |
1,299,389
-15,990
| -1% | -$1.29M |
|
517
Invesco
IVZ
$14.3B
| $112M | 0.02% |
3,652,319
-21,290
| -0.6% | -$614K |
|
|
ABCO
518
DELISTED
Advisory Board Co
ABCO
| $112M | 0.02% |
3,479,127
-412,277
| -11% | -$15.4M |
|
519
TransUnion
TRU
$15.5B
| $111M | 0.02% |
4,012,944
-479,924
| -11% | -$12.2M |
|
|
SPLS
520
DELISTED
Staples Inc
SPLS
| $109M | 0.02% |
9,921,528
+45,770
| +0.5% | +$430K |
|
521
Monster Beverage
MNST
$91.4B
| $109M | 0.02% |
9,789,624
+1,690,668
| +21% | +$18.8M |
|
|
EQC
522
DELISTED
Equity Commonwealth
EQC
| $109M | 0.02% |
3,851,553
+1,333,360
| +53% | +$36M |
|
523
Pebblebrook Hotel Trust
PEB
$2.05B
| $108M | 0.02% |
3,728,045
+226,853
| +6% | +$5.87M |
|
524
Yum! Brands
YUM
$41.2B
| $108M | 0.02% |
1,837,675
+431,620
| +31% | +$22.6M |
|
|
NATI
525
DELISTED
National Instruments Corp
NATI
| $107M | 0.02% |
3,570,009
-455,090
| -11% | -$13.1M |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.